《滬深兩市》A股三大指數開市走個別 內房股偏好 藥明康德再跌4.5%
內地去年工業企業利潤按年跌2.3%,上月增16.8%連增五個月。中國證監會經充分論證評估,暫停限售股出借,對融券效率進行限制。人民銀行今日進行5,000億元七天期逆回購操作,中標利率持平於1.8%。今日單日淨投放3,780億元。人民幣兌美元中間價今下調13點,報7.1097。
A股三大指數今早開市個別發展。滬指高開不足1點,報2,910;深成指高開13點或0.2%,報8,775;創業板指低開2點或0.1%,報1,680。
中資金融股建行(601939.SH)及工行(601398.SH)分別高開0.3%及低開0.2%。
券商股偏軟,華鑫股份(600621.SH)及首創証券(601136.SH)分別低開2.9%及2.1%。
廣州放寬限購政策,支持房地產項目合理融資需求。內房股偏好,萬科(000002.SZ)、金地集團(600383.SH)及保利發展(600048.SH)高開約2.1%至2.7%。
比亞迪(002594.SZ)及寧德時代(300750.SZ)分別高開0.02%及低開0.4%。隆基綠能(601012.SH)低開1.2%,公司指光伏產業鏈價格降至非常不理性位置。
藥明康德(603259.SH)再跌4.5%。就市傳美中特別委員會提議禁止華大基因(300676.SZ)及藥明康德等外國生物公司,藥明康德其後急開投資人電話會議,重申業務發展不對任何國家安全構成風險,並發公告澄清,指公司始終堅持「做對的事,把事做好」,生物安全法草案涉及公司內容既不恰當也不準確。華大基因低開0.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.